Clinical Study

Hypertension Control and Cardiometabolic Risk: A Regional Perspective

Table 4

Blood pressure and diabetes (% (95% CI), adjusted for age, and gender).

Total
( )
Northern Europe
( )
Southern Europe
( )
North America
( )
Middle East
( )
Asia
( )
value

SBP (mmHg)
 <12028.4 (24.78; 31.94)28.3 (21.79; 35.96)33.2 (26.56; 40.53)36.5 (27.70; 46.41)32.3 (14.11; 58.00)21.4 (15.72; 28.48)<0.0001
 120–13927.3 (25.86; 28.65)33.7 (30.86; 36.77)25.7 (23.65; 27.94)33.6 (29.39; 38.16)33.9 (23.15; 46.63)22.7 (19.92; 25.83)<0.0001
 140–15928.8 (27.69; 29.83)33.6 (31.77; 35.57)29.8 (28.12; 31.63)28.8 (25.21; 32.59)40.0 (33.26; 47.09)22.5 (20.07; 25.07)<0.0001
 160–17930.4 (28.98; 31.89)37.4 (34.96; 33.96)31.4 (29.16; 33.84)32.7 (27.24; 38.59)32.1 (25.62; 39.44)21.0 (17.62; 24.84)<0.0001
 ≥18032.6 (30.12; 35.00)34.8 (31.08; 38.77)36.5 (32.50; 40.66)16.4 (9.30; 27.44)49.5 (38.68; 60.35)26.8 (20.84; 33.64)<0.0001
value<0.00010.15710.00090.04910.13530.6222
DBP (mmHg)
 <9030.9 (29.95; 31.95)37.6 (35.77; 39.53)29.6 (27.97; 31.25)34.3 (31.51; 37.31)38.8 (31.44; 46.82)25.8 (23.58; 28.08)<0.0001
 90–9927.9 (26.76; 29.14)34.2 (32.11; 36.36)29.2 (27.32; 31.08)25.3 (20.77; 30.55)34.4 (28.23; 41.10)21.2 (18.53; 24.24)<0.0001
 100–10925.5 (23.70; 27.26)26.9 (23.92; 30.13)31.0 (28.16; 34.07)22.2 (14.84; 31.73)38.7 (30.21; 47.89)13.6 (10.43; 17.64)<0.0001
 ≥11028.1 (24.68; 31.55)31.3 (26.06; 37.12)33.3 (28.08; 38.99)18.4 (7.02; 40.17)42.7 (29.81; 56.68)16.7 (9.95; 26.69)<0.0001
value<0.0001<0.00010.36350.00020.8877<0.0001
RR (mmHg)
 uncontrolled*27.7 (26.73; 28.71)34.7 (33.30; 36.06)30.8 (29.48; 32.07)28.6 (25.81; 31.56)38.0 (33.68; 42.54)22.4 (20.55; 24.34)<0.0001
 controlled**30.4 (29.42; 31.34)34.3 (31.37; 37.33)27.1 (27.98; 29.40)35.4 (31.36; 39.70)37.1 (25.98; 49.82)22.9 (20.18; 25.96)<0.0001
value0.17830.83160.04970.01060.68240.6820

*SBP/DBP ≥140/90 in non-diabetic and ≥130/80 in diabetic patients, **<140/90 in non-diabetic and <130/80 in diabetic patients.